Annapurna Therapeutics

Biotechnology

  • Headquarters: 183 avenue de Choisy, Paris, France, 75013

Phone: NA

Founded: 2014

Employees: 0-10

Stock Exchange: NA

About Annapurna Therapeutics

Annapurna Therapeutics is a gene therapy company focused on discovering and developing new therapeutic products for people livin ... g with severe diseases. Annapurna’s product pipeline includes programs for: alpha-1 antitrypsin (A1AT) deficiency, hereditary angioedema (HAE), the cardiomyopathy associated with Friedreich’s ataxia and severe allergy. There is a significant unmet medical need for each of these diseases, and we believe that our adeno-associated virus (AAV)-based gene therapy products, by providing a one-time treatment, have the potential to make a meaningful difference in improving patients’ lives. We are passionate in our quest to serve and bring hope to patients and their families living with severe diseases, and value our relationship with patient communities and the organizations that serve them. Through our commitment to pharmaceutical research and development in an innovative, focused and ethical manner, we are dedicated to transform treatment paradigm in a range of severe diseases where treatment options are limited. Show more

Join Ampliz To Reach Decision Makers At Annapurna Therapeutics

Reach Decision Makers At
Annapurna Therapeutics

Book a Demo

Frequently Asked Questions Regarding Annapurna Therapeutics

Where are Annapurna Therapeutics’s headquarters?

Annapurna Therapeutics’s headquarters are in 183 avenue de Choisy, Paris, France, 75013

What is Annapurna Therapeutics’s industry?

Annapurna Therapeutics is in the industry of: Biotechnology

What is Annapurna Therapeutics’s official website?

Annapurna Therapeutics’s official website is www.annapurnatx.com

How many employees are working in Annapurna Therapeutics?

Annapurna Therapeutics has 0-10 employees

Company_logo Company Directory Search
Company_logo
Reach your target accounts faster with Ampliz
logo © Copyright 2023 Ampliz Pvt. Ltd.